In addition, HtrA2 has also been reported to co-localize within Lewy bodies and has been shown to be able to reduce the propensity of Parkinson-related α-synuclein seeding whilst also contributing to the removal of existing α-synuclein aggregates23,24. This evidence concerns the gene HTRA2 and Parkinson disease.